apolactoferrin: Clinical Trials

1 trial of apolactoferrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow apolactoferrin: new trials by email Literature Review of apolactoferrin trials Research Report on apolactoferrin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
Lactoferrin (Apolactoferrin), Placebo of excipient(s) will be administered - Corona Virus Infection, Middle East Respiratory Syndrome (MERS)
Phase 2UnknownNational Research Centre, Egypt5162022-02-012021-11-15

Conditions studied

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Cytokine Release Syndrome (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

National Research Centre, Egypt (1)

Countries

Egypt (1)

Top investigators

Rehab Hegazy, PhD (1)